AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 15:850-857, October 2007
© 2007 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, W. D.
Right arrow Articles by Krishnan, K. R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, W. D.
Right arrow Articles by Krishnan, K. R. R.

Article

Allelic Differences in the Brain-Derived Neurotrophic Factor Val66Met Polymorphism in Late-Life Depression

Warren D. Taylor, M.D., Stephan Züchner, M.D., Douglas R. McQuoid, B.S., David C. Steffens, M.D., M.H.S., Marcy C. Speer, Ph.D., and K. Ranga R. Krishnan, M.D.

From the Departments of Psychiatry (WDT, SZ, DRM, DCS, KRRK) and Medicine (MCS), and The Center for Human Genetics (WDT, MCS), Duke University Medical Center, Durham, NC.

Objective: The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with cognitive and neuroimaging changes. The authors examined the relationship between this polymorphism and depression in an elderly sample, hypothesizing that the Met66 allele would be associated with late-life depression.

Methods: A total of 245 elderly depressed white subjects and 94 elderly comparison white subjects completed clinical assessments and provided a blood sample for genotyping. Subjects were dichotomized as either homozygous for the Val66 allele or Met66 allele carriers. Gene frequencies were compared between groups, with separate analyses examining for differences in gene frequencies based on age of depression onset, family history, and depression history. Logistic regression models examined the relationship between genotype and depression after controlling for age, sex, and race.

Results: Depressed subjects were more likely to be Met66 allele carriers than were comparison subjects (38.8% versus 24.4%; {chi}2 = 6.13, 1 df, p = 0.0133). This relationship remained significant after controlling for covariates (Wald {chi}2 = 5.10, 1 df, p = 0.024; odds ratio: 1.92, 95% confidence interval: 1.09–3.38). There were no significant relationships between genotype and age of onset, number of episodes, or family history of depression.

Conclusion: Met66 allele carriers have almost double the odds of having geriatric depression than do Val66 allele homozygotes. This polymorphism was unrelated to other clinical characteristics of depression in later life.

Key Words: Single nucleotide polymorphism • depression • gene frequency




This article has been cited by other articles:


Home page
AJGPHome page
W. D. Taylor, S. Zuchner, D. R. McQuoid, M. E. Payne, J. R. MacFall, D. C. Steffens, M. C. Speer, and K. R. R. Krishnan
The Brain-Derived Neurotrophic Factor VAL66MET Polymorphism and Cerebral White Matter Hyperintensities in Late-Life Depression
Am J Geriatr Psychiatry, April 1, 2008; 16(4): 263 - 271.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2007 American Association for Geriatric Psychiatry